#USA #New York #Class Action #Levi Korsinsky #GSK Plc

Join the Class Action Against GSK plc

Critical Deadline Alert: April 7, 2025
Levi & Korsinsky, LLP, a well-known law firm specializing in securities litigation, has initiated a class action lawsuit against GSK plc (NYSE: GSK) on behalf of investors who experienced losses due to alleged fraudulent actions by the company.

Background of the Case

The class action centers around the period from February 5, 2020, to August 14, 2022, a time frame during which GSK is accused of making false and misleading statements regarding the removal of its popular drug, Zantac, from the market. According to the filed complaint, GSK communicated to investors that the decision to withdraw Zantac was made based on available information and discussions with regulatory bodies.

However, the lawsuit alleges that GSK was aware of essential data regarding a probable carcinogen, NDMA (N-Nitrosodimethylamine), associated with Zantac long before its market withdrawal. In essence, the filings assert that the company's reassurances to shareholders were not only inaccurate but were knowingly misleading.

Who Can Participate?

If you suffered financial losses related to GSK within the specified period, now is the time to act. To be considered for lead plaintiff status, it’s crucial to submit your application by April 7, 2025. Even if you don’t serve as a lead plaintiff, you can still be eligible for compensation as a class member.

No Financial Risk to Participants

One of the most appealing aspects of this class action is that participants are not required to cover any legal fees upfront. Eligible investors can potentially receive compensation without any obligation or out-of-pocket costs. This structure allows affected shareholders a risk-free opportunity to seek justice for their losses resulting from GSK’s alleged misconduct.

Levi & Korsinsky: Your Legal Advocate

Levi & Korsinsky has established itself as a leader in representing investors who have been harmed during corporate scandals. Over the past two decades, they have successfully recovered hundreds of millions of dollars for shareholders affected by various securities violations. The firm is known for its commitment to holding companies accountable for misleading practices.

The lawyers from Levi & Korsinsky have extensive experience in complex securities litigation and utilize a dedicated team consisting of more than 70 professionals to advocate for their clients effectively. Notably, the firm has earned its position among the top securities litigation firms in the U.S. for seven consecutive years, thanks to their proven track record.

Next Steps

If you believe you are eligible to join the class action against GSK, you must reach out to Levi & Korsinsky to initiate the process for claiming your rights as an investor. You can contact Joseph E. Levi, Esq., via email at jlevi@zlk.com or by phone at (212) 363-7500. Alternatively, submit your information via the linked form provided in the complaints.

For further details about the case and your eligibility, follow the link: GSK Lawsuit Submission Form

Don’t miss this opportunity to reclaim your losses! The pursuit of justice is within your grasp, but action must be taken promptly before the deadline approaches.